Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast tissue cell growth in a Northwestern University study.

A new FDA application for vepdegestrant offers hope for advanced breast cancer patients with ESR1 mutations, showcasing ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...

Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...

Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.

A major new study found the risk of death or the cancer recurring dropped significantly in people who took on exercise ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

Patients who have been treated for colon cancer could cut their risk of death by 37% if they stick to a structured exercise ...

Head and neck cancer affects the Black community differently. These questions will help you make informed decisions about ...

On June 4, analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Immix Biopharma, Inc. (NASDAQ:IMMX) with a ...

When journalist Jon Gluck learned he had multiple myeloma, doctors told him he had 18 months to live. That was 20 years ago. ...